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Background: The use of multiple medicines is very frequent among the elderly, allowing them to perceive
more often adverse side effects from drugs and present undesirable drug interactions.
Methods: This article presents a cross-sectional survey about the use of medicines among 300 elderly
Brazilians, equally divided into institutionalized and community-dwelling groups.
Results: The average daily intake of medicines is 3.2 among institutionalized elderly, a higher (p< 0.001)
number when compared with community-dwelling elderly, who takes an average of 1.8 medicines daily.
The most commonly used medications are antihypertensives (58.0%), diuretics (23.0%), nonsteroidal anti-
inﬂammatory drugs (22.7%), supplements (21.7%), antidiabetics (16.3%), and antiulcerants (14.0%).
Antiulcerants, diuretics, supplements, and central nervous system drugs are more frequently used by
institutionalized than by community-dwelling elderly.
Conclusion: In this Brazilian elderly sample, the most widely used medicines were antihypertensives,
diuretics, and nonsteroidal anti-inﬂammatory drugs, and institutionalized used more medications than
community-dwelling elderly.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
The growth of elderly population is a worldwide phenomenon,
which also affects developing countries, such as Brazil. According to
the Brazilian Institute of Geography and Statistics1, individuals
aging 65 years and older are 6.5% of the Brazilian population
nowadays. Considering the predictable rising of the elderly pop-
ulation, however, it should achieve 22.7% of the entire Brazilian
population by the year 2050.
Elderly patients with multiple chronic diseases are likely to
receive care from several health care providers, and each of them
may prescribe a different drug. That is a common cause for multiple
drug use (polypharmacy) among the elderly, making this pop-
ulationmore susceptible to iatrogenic effects or drugs interaction2,3.
Patients older than 65 years have a signiﬁcantly increased risk
for drug-related problems not only because aging affects how their
body handles medications but also because they take more drugsment of Biosciences and Oral
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s Campos 12245-010, Brazil.
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erest.
iwan Society of Geriatric Emergenwhen compared with younger patients. As a result, the more drugs
they take, the higher the risk of drug interactions. The estimated
incidence of drug interactions rises from 6% in patients taking two
medications to as high as 50% in patients taking ﬁve medicines4.
Polypharmacy is even more common in institutionalized
patients than among the community-dwellers. Furthermore,
institutionalized elderly are more susceptible to adverse drug
reactions5,6.
Most of the medicines prescribed for young adults are not
appropriate to be used by the elderly7. However, some of these
inappropriate medicines are often prescribed to the elderly maybe
because of its low cost8,9 and misinformation about medicines use
among the elderly10,11.
There are several studies5,6,12 about the use of medicines among
the elderly in multiple countries. However, there is little available
literature about the use of medicines by Brazilian elderly13, and this
is an important issue for the increasing number of geriatric health
care providers in Brazil and other developing countries.
Considering the above, the present study aimed to investigate
which medicines are most commonly used by a Brazilian sample
composed of institutionalized and community-dwelling elderly. As
it was previously described by other elderly samples13e15 and
considering the most prevalent disease among Brazilian elderly16,
we hypothesize that the most commonly used medicines arecy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 2
Distribution the most commonly used pharmacological classes between institu-
tionalized and community-dwelling elderly
Pharmacological
class
Institutionalized Community
dwelling
p
n % n %
NSAID 33 22.0 35 23.3 0.783
Antidiabetics 27 18.0 22 14.7 0.435
Antihypertensives 82 54.7 92 61.3 0.242
Antiulcerants 32 21.3 10 6.7 <0.001*
Diuretic 42 28.0 27 18.0 0.040*
Supplement 52 34.7 13 8.7 <0.001*
NSAID¼Nonsteroidal anti-inﬂammatory drug.
Asterisk (*) indicates a statistically signiﬁcant difference (two ratios equality test).
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are those freely available in the public health care units14.
2. Material and Methods
2.1. Participants
Of the total number of elderly residents of São José dos Campos,
Brazil, 300 were evaluated, representing about 1.27% of the city’s
elderly population, as previously described16. Using the Minitab
(Minitab Inc., State College, PA, USA) power and sample size tool,
which considered the aforementioned percentage of the city pop-
ulation, this study sample received a sample’s power score of 0.94.
This score indicated that the sample was fairly representative of
this city’s elderly population. The participants were equally divided
into institutionalized and community-dwelling groups. The
average age of the participants was 74.3. Women represented 70.3%
of the total sample, a percentage similar of those obtained previ-
ously among elderly sample in this Brazilian region1,16.
This study was previously approved by the University of Vale do
Paraíba Ethical Committee (protocol number L102/2004/CEP), and
all the participants (or their tutors) signed an informed consent
form before participating in this survey.
2.2. Data registration and analysis
The medicines used by each individual were obtained directly
by the patient and/or caregiver and checked using patients’ records
(when they are institutionalized) and properly registered. The data
were than tabulated, drugs were classiﬁed, and a descriptive
statistics was performed. Mann-Whitney U test was used to
compare the number of used medicines among the two groups and
two ratios equality test was used to compare the groups about the
use of different medicines.
3. Results
The average number of daily taken medicines was higher
(p< 0.001, Mann-Whitney U test) among institutionalized elderly
(3.2) when compared with community-dwellers (1.8). Among the
entire sample, 86.3% used some medicine and this percentage is
higher (p< 0.001, two ratios equality test) among the institution-
alized elderly (92%) when compared with community dwellers
(80.7%).
Table 1 shows themost commonly used pharmacological classes
and respective drugs. The most commonly used medications are
antihypertensives (58.0%), diuretics (23.0%), nonsteroidal anti-
inﬂammatory drugs (22.7%), supplements (21.7%), antidiabetics
(16.3%), and antiulcerants (14.0%).
Table 2 shows the distribution the most commonly used phar-
macological classes between institutionalized and community-
dwelling elderly. It was possible to verify that antiulcerants
(p< 0.001, two ratios equality test), diuretics (p¼ 0.040, two ratios
equality test), and supplements (p< 0.001, two ratios equality test)Table 1
Most commonly used pharmacological classes and respective drugs
Pharmacological class Most prescribed drugs (% among its class)
Antihypertensives Captopril (66.7%), methyldopa (11.5%), ver
Diuretics Hydrochlorothiazide (76.8%), chlortalidone
NSAID Acetylsalicylic acid (72.1%), diclofenac (13.
Supplement Vitamin complex (33.8%), iron (26.2%), gin
Antidiabetics Glibenclamide (49.0%), chlorpropamide (26
Antiulcerants Ranitidine (76.2%), omeprazole (11.9%), cim
NSAID¼Nonsteroidal anti-inﬂammatory drug.are more frequently used by institutionalized than community-
dwelling elderly.
Neuroleptics, ansiolitic, antiepiletic, antiemetic, sedative-
hypnotic, antidepressant, and antipsychotic drugs were less
frequent than the above-mentioned pharmacological classes and
were joined in a group called central nervous system (CNS) medi-
cines. Table 3 presents the distribution of this medication group
into the sample. Most individuals in the entire sample did not use
CNS medicines, as well as in the community-dwelling group.
However, these drugs were more frequently used (p< 0.001, two
ratios equality test) by institutionalized (59.3%) than by
community-dwelling elderly (14.7%).4. Discussion
Polypharmacy is a very common event among institutionalized
elderly5,6. In this study, institutionalized elderly take signiﬁcantly
more medicines than community-dwellers. This was also previ-
ously observed in a Canadian sample6, from which 97% of institu-
tionalized elderly were current medication users (medication use
in the 2 days before their interview), compared with 76% among
community-dwellers.
Previously, Brazilian studies have found an average from 3 daily
used medicines among institutionalized elderly17 to 3.715, similar
with those encountered in the present study. Other countries,
however, present a higher number of daily used medicines. In
Finland, 7.9 medicines were taken daily by institutionalized
elderly5. Fifty-three percent of Canadian institutionalized elderly
and 13% of community-dwellers were currently taking ﬁve or more
different medications6. At the United States, most older home care
patients were taking more than ﬁve prescribed medicines18.
On one side, the relatively low usage of medicine among
Brazilian elderly should be seen as a positive fact because it reduces
the risk of iatrogenic drug effects and drug interactions. On the
other side, it might reﬂect the lower economic budget of Brazilian
elderly because costs play an important role on medicines selection
and buying8,9.
As it was hypothesized earlier, the most frequently used medi-
cines among our sample were antihypertensives and diuretics.n %
apamil (5.2%) 174 58.0
(8.7%), spironolactone (7.2%) 69 23.0
2%), metamizole (5.9%) 68 22.7
kgobiloba (10.8%) 65 21.7
.5%), insulin (12.2%) 49 16.3
etidine (9.5%) 42 14.0
Table 3
Distribution of CNS medicines use among the groups
CNS medicines use n % p
Entire sample 111 37.0 <0.001*
Institutionalized 89 59.3
Community dwelling 22 14.7
CNS¼ central nervous system.
Asterisk (*) indicates a statistically signiﬁcant difference (two ratios equality test).
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Benvegnú14 in 2008, who have observed the use of antihyperten-
sives by 21.3% of their sample and diuretics by 11.3%. Both
pharmacological classes were commonly used in Brazil to control
hypertension, the most commonly observed disease among
Brazilian elderly16.
Furthermore, almost all drugs prescribed for the elderly inves-
tigated herein presented low or relatively low cost, which
contributes to the high frequency of use of these drugs. As observed
earlier14, medicines more commonly used by the elderly were
those free of cost in the basic health care system. Some of the most
frequently used drugs in our sample, such as captopril, hydro-
chlorothiazide, glibenclamide, and insulin, receive governmental
subsidy and acquired by low income population by nearly 10% of
the real cost. Additionally, from the drugs related herein, ace-
tylsalicylic acid, metamizole, captopril, verapamil, methyldopa,
hydrochlorothiazide, spironolactone, iron, glibenclamide, insulin,
ranitidine, and omeprazole were considered as essential medicines
by the Brazilian Health Ministry. By doing so, when available and
prescribed by public health carers, it should be freely acquired by
the population.
Institutionalized elderly used CNS medicines more often than
community dwellers, and it presented a similar frequency (59.3%)
compared with those (65%) observed among institutionalized
Americans12. Considering the potential adverse drug reactions
related to CNS medicines among the elderly, the use of these drugs
should be done very carefully, with constant monitoring.
The medical literature presents several criteria for drug
prescribing for the elderly, aiming to reduce the risks of iatrogenic
interventions during medicine therapy for the elderly. One of the
most commonly used is the Beers-Fick criteria. According to these
criteria7, some medicines are considered inappropriate to be used
by the elderly, independently of the diagnosis or clinical condition.
These medicines should not be used because of the high risk of side
effects or because of the existence of more secure medicines to
substitute them7,19.
Methyldopa is not considered to be appropriate for using by the
elderly patients because it should cause bradycardia and exacerbate
depression among these patients7. Chlorpropamide is also consid-
ered inappropriate for the elderly because it presents prolonged
half-life and should cause severe hypoglycemia7,20. However, it is
a frequently used medicine by the elderly in the United States21 but
not in The Netherlands22 and Finland8. High iron doses (ferrous
sulfate over 325 mg/d) should raise the incidence of constipation
and are therefore considered inappropriate to be used by the
elderly7. However, a weak point of the present study methods was
the absence of drug dosage registers. Without dosage registers, it is
not possible to verify dosage-related problems.
Considering the restrictions stated by the Beers-Fick criteria, the
above-mentioned medicines were not often encountered among
our elderly sample: methyldopa (6.7%), iron supplements (5.7%),
and chlorpropamide (4.3%). Furthermore, the most commonly used
medicines in the investigated sample [captopril (38.7%), hydro-
chlorothiazide (17.7%), acetylsalicylic acid (16.4%), and glibencla-
mide (8.0%)] were not cited as potentially inappropriatemedications to the elderly, independent of diagnoses or clinical
conditions, by the Beers-Fick criteria.
However, because some inappropriate medicines for elderly use,
such as methyldopa, should be freely available to the population,
health care providers should be aware of its inappropriateness for
using by elderly patients.
New research efforts on this ﬁeld should focus on how to avoid
the usage of potential inappropriate medicine and the occurrence
of adverse drug reactions to promote the best possible quality of
medical treatment. In recent studies conducted in the United
States10 and Denmark11, the researchers found a decreased number
of inappropriate medicines given to elderly patients after the
implementation of programs to elucidate topics on prescription to
the elderly. These programs included, for example, educational
meetings, written recommendations, and telephonic contact with
medicine prescribers.
Similar programs could count on government support, as well as
multidisciplinary health teams, including physicians, pharmacists,
dentists, and other health care professionals to improve profes-
sionals’ knowledge about elderly medication therapies. The
programs should also focus on institutionalized elderly because
this group seems to be even more vulnerable to problems of pol-
ypharmacy. After the implementation of educational programs,
new epidemiological studies should be done to ascertain the
impact of the programs.
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